Skip to Main Content

Author Details

Gong-Hong Wei
Fudan University Shanghai Cancer
2004
64
24
PMIDPaper TitleJournal TitlePublished Year
36711639Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of <i>RUVBL1</i> and prostate cancer progression.bioRxiv2023
37526345Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma.Adv Sci (Weinh)2023
37550764GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression.J Exp Clin Cancer Res2023
37541187Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.Am J Hum Genet2023
37496999SDC2 Stabilization by USP14 Promotes Gastric Cancer Progression through Co-option of PDK1.Int J Biol Sci2023
37174115Genetic Polymorphisms of the Telomerase Reverse Transcriptase Gene in Relation to Prostate Tumorigenesis, Aggressiveness and Mortality: A Cross-Ancestry Analysis.Cancers (Basel)2023
35140242Human transcription factor protein interaction networks.Nat Commun2022
35773413Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions.Oncogene2022
35505422VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells.Cell Biosci2022
35395421Single-cell transcriptomics reveals cell type diversity of human prostate.J Genet Genomics2022
35419596Comprehensive assessment of cellular senescence in the tumor microenvironment.Brief Bioinform2022
36443337Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG.Nat Commun2022
35968571Genome-Wide 3'-UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk-Associated Functional Loci at 8p21.2 in Chinese Population.Adv Sci (Weinh)2022
35865474Editorial: Precision Medicine and Translational Research in Urological Oncology.Front Oncol2022
36094642UBE3D Is Involved in Blue Light-Induced Retinal Damage by Regulating Double-Strand Break Repair.Invest Ophthalmol Vis Sci2022
36263014Transcriptome and DNA methylome analysis of peripheral blood samples reveals incomplete restoration and transposable element activation after 3-months recovery of COVID-19.Front Cell Dev Biol2022
35264579An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression.Nat Commun2022
33037065The Amino-Terminal Oligomerization Domain of Angiopoietin-2 Affects Vascular Remodeling, Mammary Gland Tumor Growth, and Lung Metastasis in Mice.Cancer Res2021
33741908CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.Nat Commun2021
33870225Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.STAR Protoc2021
34858826Large Multicohort Study Reveals a Prostate Cancer Susceptibility Allele at 5p15 Regulating <i>TERT via</i> Androgen Signaling-Orchestrated Chromatin Binding of E2F1 and MYC.Front Oncol2021
34560228Mechanistic insights into genetic susceptibility to prostate cancer.Cancer Lett2021
33996483Expanding luminal epitheliums as cells of origin for prostate cancer.Asian J Urol2021
32722848Exome Sequencing Reveals a Phenotype Modifying Variant in ZNF528 in Primary Osteoporosis With a COL1A2 Deletion.J Bone Miner Res2020
31768607A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin.Cell Mol Life Sci2020
31131683Illumination of cell cycle progression by multi-fluorescent sensing system.Cell Cycle2019
31635067Enhancer Dysfunction in 3D Genome and Disease.Cells2019
31013831The Role of HOX Transcription Factors in Cancer Predisposition and Progression.Cancers (Basel)2019
31122963Association between homocysteine, vitamin B <sub><sub>12</sub></sub> , folic acid and erectile dysfunction: a cross-sectional study in China.BMJ Open2019
28927585Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.Eur Urol2018
30157291ANO7 is associated with aggressive prostate cancer.Int J Cancer2018
30157244Whole exome sequencing in Finnish families identifies new candidate genes for osteoarthritis.PLoS One2018
30181389Synergistic Interaction of <i>HOXB13</i> and <i>CIP2A</i> Predisposes to Aggressive Prostate Cancer.Clin Cancer Res2018
30033361Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.Cell2018
30525094Oncogenic regulatory circuits driven by 19q13 rs11672691 underlies prostate cancer aggressiveness.Mol Cell Oncol2018
29572226A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer.Cancer Res2018
29789573High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing.Nat Commun2018
28604746Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT.Oncogene2017
29387551Combined immunotherapy for advanced prostate cancer: Empowering the T cell army.Asian J Urol2017
29061142Systematic identification of regulatory variants associated with cancer risk.Genome Biol2017
29169923Ataxin-10 is involved in Golgi membrane dynamics.J Genet Genomics2017
28598379Genomic Insight into the Role of lncRNA in Cancer Susceptibility.Int J Mol Sci2017
28674394Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression.Sci Rep2017
28831136Multi-factors including Inflammatory/Immune, Hormones, Tumor-related Proteins and Nutrition associated with Chronic Prostatitis NIH IIIa+b and IV based on FAMHES project.Sci Rep2017
26950096Gene regulatory mechanisms underpinning prostate cancer susceptibility.Nat Genet2016
26603474Targeted re-sequencing of linkage region on 2q21 identifies a novel functional variant for hip and knee osteoarthritis.Osteoarthritis Cartilage2016
27705936Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.Oncotarget2016
27819261SIRT1 deacetylates the cardiac transcription factor Nkx2.5 and inhibits its transcriptional activity.Sci Rep2016
27803324Structural basis for DNA recognition by STAT6.Proc Natl Acad Sci U S A2016
26979803Chromatin interactions and candidate genes at ten prostate cancer risk loci.Sci Rep2016
  • 1 - 50 of 64

Recommended Authors

Yunpeng Gao
University of Texas Southwestern Medical Center at Dallas
Career Start Year 2017
Number of shared co-authors 3
Xiaoyu Wang
Fred Hutchison Cancer Center
Career Start Year 2015
Number of shared co-authors 1
Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year 2012
Number of shared co-authors 3
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
Suhn K Rhie
Keck School of Medicine of USC
Career Start Year 2009
Number of shared co-authors 1
Venkat S Malladi
UT Southwestern Medical Center
Career Start Year 2008
Number of shared co-authors 1
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 15
Ram S Mani
UT Southwestern Medical Center
Career Start Year 2008
Number of shared co-authors 7
John R Prensner
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 11
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
Harmen J G van de Werken
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 1
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 0
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 1
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 14
Tesa M Severson
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2002
Number of shared co-authors 13
Howard H Yang
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Juliet D French
QIMR Berghofer Medical Research Institute
Career Start Year 2001
Number of shared co-authors 2
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Benjamin P Berman
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Career Start Year 2000
Number of shared co-authors 0
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 0
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 2
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 2
Peter C Scacheri
Case Western Reserve University School of Medicine
Career Start Year 1995
Number of shared co-authors 2
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 7
Matthew L Freedman
Dana-Farber Cancer Institute
Career Start Year 1993
Number of shared co-authors 21
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 13
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0

Collaborators

Jihan Xia
University of Oulu
Co-authored papers 8
Jian Yan
Co-authored papers 5
Jussi Taipale
Co-authored papers 5
Liang Wang
H. Lee Moffitt Cancer Center
Co-authored papers 5
Yijun Tian
Naval Medical University
Co-authored papers 5
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 4
Fredrik Wiklund
Co-authored papers 4
Jianfeng Xu
Co-authored papers 4
Timothy R Hughes
University of Toronto
Co-authored papers 3
Martin Enge
Karolinska Institutet
Co-authored papers 3
Johan Lindberg
Karolinska Institute
Co-authored papers 2
Stephen N Thibodeau
Mayo Clinic
Co-authored papers 2
Jing Li
Center for Translational Medicine, Second Military Medical University
Co-authored papers 2
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 2
Shancheng Ren
Shanghai Changzheng Hospital
Co-authored papers 2
Lars Egevad
Karolinska Institute
Co-authored papers 2
Hou-Zao Chen
Co-authored papers 2
Ao Liu
Co-authored papers 1
Junjie T Hua
School of Public Health, Sun Yat-sen University
Co-authored papers 1
Daniel Klevebring
Karolinska Institutet
Co-authored papers 1
Helen J Ross
Mayo Clinic
Co-authored papers 1
Mark J Dunning
The Medical School, The University of Sheffield
Co-authored papers 1
Jun Wang
Zhongnan Hospital of Wuhan University
Co-authored papers 1
Silvia Halim
University of Oxford
Co-authored papers 1
Stanley Zhou
Princess Margaret Cancer Research Centre
Co-authored papers 1
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 1
Kathleen E Houlahan
University of California los angeles
Co-authored papers 1
Yong Zeng
College of Life Science, Hunan Normal University
Co-authored papers 1
Amina Zoubeidi
University of British Columbia
Co-authored papers 1
Miranda Wang
Princess Margaret Cancer Center/University Health Network
Co-authored papers 1
Release 1.2